Scupham D W, McCarthy B M, Harmony J A
Cell Immunol. 1987 Sep;108(2):378-95. doi: 10.1016/0008-8749(87)90221-8.
The activation of T lymphocytes was regulated in vitro by low-density lipoproteins (LDL). Not all prereplicative events induced by the oxidative enzymatic mitogens neuraminidase and galactose oxidase (NAGO) were susceptible to inhibition by LDL. The accessory cell-independent early blastogenic response was not suppressed. LDL suppressed accessory cell-dependent responses, and the extent of LDL suppression, depended on the concentration of transferrin. A gradient of transferrin determined the point in the cell cycle at which NAGO-primed lymphocytes were suppressed by LDL. When transferrin was low (0-10 micrograms/ml) and in serum-free medium (SFM), LDL suppressed the expression of cell surface receptors for interleukin-2 (IL-2R) and transferrin (TfR), the late blastogenic response prior to DNA replication (72 hr), and DNA replication. At higher levels of transferrin, about 100 micrograms/ml, the LDL-suppressed cells were IL-2R+, TfR+ and responsive to IL-2, but did not enter S phase. LDL suppression could be ablated by IL-2 and by high levels of transferrin (250-1000 micrograms/ml). In RPMI medium containing serum (FBS), the pattern of LDL suppression was different from that in SFM: fully activated IL-2R+, TfR+ lymphocytes were unresponsive to exogenous IL-2, suggesting that they were blocked at the G1/S boundary. This block was also relieved by transferrin (greater than 100 micrograms/ml). The data suggest that the interplay between transferrin and LDL is a critical factor in the NAGO-induced stimulation of T lymphocytes. LDL and transferrin exert negative and positive control of lymphocyte activation, respectively. In SFM, LDL appear to alter transferrin utilization by accessory cells; in RPMI-FBS, by fully activated T lymphocytes.
低密度脂蛋白(LDL)在体外对T淋巴细胞的激活具有调节作用。并非氧化酶促有丝分裂原神经氨酸酶和半乳糖氧化酶(NAGO)诱导的所有复制前事件都易受LDL抑制。不依赖辅助细胞的早期母细胞化反应未被抑制。LDL抑制依赖辅助细胞的反应,且LDL抑制的程度取决于转铁蛋白的浓度。转铁蛋白梯度决定了在细胞周期中NAGO预处理的淋巴细胞被LDL抑制的时间点。当转铁蛋白水平较低(0 - 10微克/毫升)且在无血清培养基(SFM)中时,LDL抑制白细胞介素-2(IL-2R)和转铁蛋白(TfR)的细胞表面受体表达、DNA复制前的晚期母细胞化反应(72小时)以及DNA复制。在较高转铁蛋白水平(约100微克/毫升)时,被LDL抑制的细胞IL-2R阳性、TfR阳性且对IL-2有反应,但不进入S期。IL-2和高水平转铁蛋白(250 - 1000微克/毫升)可消除LDL抑制。在含血清(FBS)的RPMI培养基中,LDL抑制模式与SFM中不同:完全活化的IL-2R阳性、TfR阳性淋巴细胞对外源IL-2无反应,表明它们在G1/S边界被阻断。转铁蛋白(大于100微克/毫升)也可解除这种阻断。数据表明,转铁蛋白与LDL之间的相互作用是NAGO诱导的T淋巴细胞刺激中的关键因素。LDL和转铁蛋白分别对淋巴细胞激活发挥负向和正向控制作用。在SFM中,LDL似乎改变辅助细胞对转铁蛋白的利用;在RPMI - FBS中,则改变完全活化的T淋巴细胞对转铁蛋白的利用。